News
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Cushman & Wakefield Releases Midpoint 2025 Outlook
Cushman & Wakefield (NYSE: CWK) today released its Midpoint 2025 Outlook, providing a comprehensive snapshot of the U.S. economy and commercial real estate markets as they navigate a complex
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Registration Now Open for ICMI’s Contact Center Expo 2025
ICMI’s Contact Center Expo, which brings contact center industry professionals together to tackle the challenges and opportunities that will enable positive growth and change in the industry, today
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant epilepsy (DRE)
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced completion of the CORE-VNS study, evaluating comprehensive outcomes of real-world evidence for more than
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc